Strategies for the preclinical and clinical characterization of immunogenicity.
Koren
E
E
Department of Clinical Immunology, Amgen Inc, Thousand Oaks, California 91320, USA. ekoren@amgen.com
Mytych
D
D
Koscec
M
M
Ferbas
J
J
Gupta
S
S
Moxness
M
M
Swanson
S
S
D000818:Animals; D001688:Biological Products / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D004341:Drug Evaluation / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D008252:Macaca fascicularis; D011506:Proteins / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D051381:Rats
D001688:Biological Products; D011506:Proteins